Literature DB >> 9933797

Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma.

M Lahn1, P Fisch, G Köhler, R Kunzmann, I Hentrich, H Jesuiter, D Behringer, B Muschal, H Veelken, P Kulmburg, D N Iklé, A Lindemann.   

Abstract

OBJECTIVES: The objectives of this study were to assess cytokine secretion in human renal cell carcinoma (RCC) and to identify cytokines contributing to the immunomodulatory effect of tumor cells.
METHODS: Cytokine secretion in the supernatant of primary tumor cell cultures (PTCC) and corresponding cell lines (CL) was assayed using ELISA. Tumor cells were characterized by morphology, immunocytochemistry, and flow-cytometric analysis. Tumor-cell-induced T cell activation was determined by coculture of gamma delta and alpha beta T cell clones with tumor CL.
RESULTS: We assessed the cytokine secretion of tumor cells from 27 PTCC and their corresponding CL (3/27) of RCC. We found that RCC predominantly produced both pro-inflammatory and T-cell-inhibitory cytokines, such as IL-8, IL-6, GM-CSF, TNF-alpha, IL-10 and TGF-beta 1. CL were adapted to serum-free medium which may prove as a useful tool in future studies of cytokine secretion in RCC. In addition, we used gamma delta and alpha beta T cell clones to assess the immunomodulatory effect of tumor cells from RCC and found that predominantly gamma delta T cells were activated by RCC.
CONCLUSIONS: Our data suggest that RCC produce large amounts of both pro-inflammatory and T-cell-inhibitory cytokines that potentially could influence the immune response of the host, especially tumor-specific cytotoxic T cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9933797     DOI: 10.1159/000019821

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  11 in total

Review 1.  Local treatment of metastatic cancer--killing the seed or disturbing the soil?

Authors:  Scott C Morgan; Chris C Parker
Journal:  Nat Rev Clin Oncol       Date:  2011-06-07       Impact factor: 66.675

2.  MicroRNA-1 and MicroRNA-21 Individually Regulate Cellular Growth of Non-malignant and Malignant Renal Cells.

Authors:  Hannes Ahrend; Anne Kaul; Susanne Ziegler; Lars-Ove Brandenburg; Uwe Zimmermann; Alexander Mustea; Martin Burchardt; Patrick Ziegler; Matthias B Stope
Journal:  In Vivo       Date:  2017 Jul-Aug       Impact factor: 2.155

3.  Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

Authors:  R Houston Thompson; Michael D Gillett; John C Cheville; Christine M Lohse; Haidong Dong; W Scott Webster; Kent G Krejci; John R Lobo; Shomik Sengupta; Lieping Chen; Horst Zincke; Michael L Blute; Scott E Strome; Bradley C Leibovich; Eugene D Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

4.  Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma.

Authors:  K Hotta; M Sho; K Fujimoto; K Shimada; I Yamato; S Anai; N Konishi; Y Hirao; K Nonomura; Y Nakajima
Journal:  Br J Cancer       Date:  2011-09-20       Impact factor: 7.640

5.  Different Cytokine and Chemokine Expression Patterns in Malignant Compared to Those in Nonmalignant Renal Cells.

Authors:  Nadine Gelbrich; Hannes Ahrend; Anne Kaul; Lars-Ove Brandenburg; Uwe Zimmermann; Alexander Mustea; Martin Burchardt; Denis Gümbel; Matthias B Stope
Journal:  Anal Cell Pathol (Amst)       Date:  2017-07-09       Impact factor: 2.916

Review 6.  Immune consequences of anti-angiogenic therapyin renal cell carcinoma.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Claudine Kieda
Journal:  Contemp Oncol (Pozn)       Date:  2018-03-05

Review 7.  Cytoreductive nephrectomy in the current treatment algorithm.

Authors:  Teele Kuusk; Bernadett Szabados; Wing Kin Liu; Thomas Powles; Axel Bex
Journal:  Ther Adv Med Oncol       Date:  2019-09-27       Impact factor: 8.168

Review 8.  Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.

Authors:  Scott J Dawsey; Steven C Campbell; Moshe C Ornstein
Journal:  Curr Oncol       Date:  2021-05-20       Impact factor: 3.677

9.  Nephrectomy improves the survival of metastatic renal cell cancer patients with moderate to good performance status-results from a Finnish nation-wide population-based study from 2005 to 2010.

Authors:  Lauri Laru; Hanna Ronkainen; Pasi Ohtonen; Markku H Vaarala
Journal:  World J Surg Oncol       Date:  2021-06-28       Impact factor: 2.754

10.  Expression level of CXCL7 in peripheral blood cells is a potential biomarker for the diagnosis of renal cell carcinoma.

Authors:  Toshiro Kinouchi; Motohide Uemura; Cong Wang; Yu Ishizuya; Yoshiyuki Yamamoto; Takuji Hayashi; Kyosuke Matsuzaki; Wataru Nakata; Takahiro Yoshida; Kentaro Jingushi; Atsunari Kawashima; Takeshi Ujike; Akira Nagahara; Kazutoshi Fujita; Ryoichi Imamura; Yuko Ueda; Kaori Kitae; Kazutake Tsujikawa; Norio Nonomura
Journal:  Cancer Sci       Date:  2017-10-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.